These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3879419

  • 1. Long term lorcainide therapy guided by electrophysiology studies.
    Somberg J, Butler B, Flowers D, Tepper D, Torres V.
    Acta Cardiol; 1985; 40(6):621-36. PubMed ID: 3879419
    [Abstract] [Full Text] [Related]

  • 2. Long-term lorcainide therapy in patients with ventricular tachycardia.
    Somberg J, Butler B, Flowers D, Keefe D, Torres V, Miura D.
    Am Heart J; 1985 Jan; 109(1):33-40. PubMed ID: 3966330
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC, Butler B, Flowers D, Keefe D, Torres V, Miura D.
    Am J Cardiol; 1984 Aug 13; 54(4):43B-48B. PubMed ID: 6465046
    [Abstract] [Full Text] [Related]

  • 4. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC, Butler B, Flowers D, Tepper D, Maguire W, Willens H, Keren G, Miura D.
    Am J Cardiol; 1984 Aug 13; 54(4):49B-54B. PubMed ID: 6465047
    [Abstract] [Full Text] [Related]

  • 5. Lorcainide therapy for the high-risk patient post myocardial infarction.
    Somberg JC, Butler B, Torres V, Flowers D, Tepper D, Keefe D, Miura DS.
    Am J Cardiol; 1984 Aug 13; 54(4):37B-42B. PubMed ID: 6465045
    [Abstract] [Full Text] [Related]

  • 6. Lorcainide therapy in a cardiac arrest population.
    Somberg JC, Laux B, Wynn J, Keefe D, Miura DS.
    Am Heart J; 1986 Apr 13; 111(4):648-53. PubMed ID: 3953387
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM.
    Circulation; 1978 Dec 13; 58(6):986-97. PubMed ID: 709782
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the electrophysiologic effects of intravenous and oral lorcainide in patients with recurrent ventricular tachycardia.
    Echt DS, Mitchell LB, Kates RE, Winkle RA.
    Circulation; 1983 Aug 13; 68(2):392-9. PubMed ID: 6861314
    [Abstract] [Full Text] [Related]

  • 10. [Clinical-electrophysiological study of the effect of lorcainide on induction of ventricular tachycardia (author's transl)].
    Breithardt G, Seipel L, Abendroth RR.
    Z Kardiol; 1981 Jul 13; 70(7):530-5. PubMed ID: 7269732
    [Abstract] [Full Text] [Related]

  • 11. Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide.
    Wynn J, Torres V, Flowers D, Mizruchi M, Keefe D, Miura D, Somberg J.
    Am Heart J; 1986 Apr 13; 111(4):632-8. PubMed ID: 3953384
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical and electrophysiologic effects of chronic lorcainide therapy in refractory ventricular tachycardia.
    Saksena S, Rothbart ST, Cappello G, Bernstein A, Somani P.
    J Am Coll Cardiol; 1983 Sep 13; 2(3):538-44. PubMed ID: 6875117
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
    Miura DS, Schwartz J, Laux B, Wynn J, Keefe D, Somberg JC.
    J Clin Pharmacol; 1987 Jul 13; 27(7):481-6. PubMed ID: 3654999
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL, Buxton AE, Sadowski LM, Josephson ME.
    Circulation; 1983 Jan 13; 67(1):30-7. PubMed ID: 6847803
    [Abstract] [Full Text] [Related]

  • 18. Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate.
    Keren G, Miura DS, Somberg JC.
    Am Heart J; 1984 Apr 13; 107(4):638-43. PubMed ID: 6702556
    [Abstract] [Full Text] [Related]

  • 19. Antiarrhythmic effects of cibenzoline.
    Miura DS, Keren G, Torres V, Butler B, Aogaichi K, Somberg JC.
    Am Heart J; 1985 Apr 13; 109(4):827-33. PubMed ID: 3984837
    [Abstract] [Full Text] [Related]

  • 20. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL, Sze DY, Keefe DL, Swerdlow CD, Echt DS, Griffin JC, Winkle RA, Mason JW.
    Circulation; 1982 Dec 13; 66(6):1205-10. PubMed ID: 6814784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.